Kingworld Med, officially known as Kingworld Medical Technology Co., Ltd., is a prominent player in the medical technology industry, headquartered in China (CN). Founded in 2005, the company has established itself as a leader in the development and manufacturing of advanced medical devices and healthcare solutions, with a strong operational presence across Asia and Europe. Specialising in innovative diagnostic equipment and therapeutic devices, Kingworld Med is recognised for its commitment to quality and cutting-edge technology. The company’s core products, which include state-of-the-art imaging systems and patient monitoring solutions, are designed to enhance clinical outcomes and improve patient care. With a focus on research and development, Kingworld Med has achieved significant milestones, positioning itself as a trusted name in the healthcare sector.
How does Kingworld Med's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Kingworld Med's score of 25 is higher than 55% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Kingworld Med reported carbon emissions of approximately 2,030,000 kg CO2e, all of which fall under Scope 2 emissions. This represents a slight decrease from 2022, where emissions were about 2,055,000 kg CO2e. In 2021, the company recorded total emissions of approximately 2,234,000 kg CO2e, again solely from Scope 2. Notably, Kingworld Med has not disclosed any Scope 1 or Scope 3 emissions in the available data. Despite the fluctuations in emissions over the years, there are currently no specific reduction targets or climate pledges outlined by Kingworld Med. The company’s commitment to addressing climate change remains vague, with no documented initiatives or targets for emissions reduction. As a result, Kingworld Med's climate strategy appears to be in the early stages, lacking defined goals for future emissions reductions.
Access structured emissions data, company-specific emission factors, and source documents
Add to project2019 | 2021 | 2022 | 2023 | |
---|---|---|---|---|
Scope 1 | - | - | - | - |
Scope 2 | 1,556,000 | 0,000,000 | 0,000,000 | 0,000,000 |
Scope 3 | - | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Kingworld Med is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.